Koers Rock Creek Pharmaceuticals Inc Nasdaq
Aandelen
US7720812046
Farmaceutische producten
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 8,21 mln. 7,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -38 mln. -35,35 mln. | Nettowinst (verlies) 2015 | -6 mln. -5,58 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 45K 41,86K | Nettoschuld 2015 | 19,86 mln. 18,47 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-0,87
x | K/w-verhouding 2015 |
-1,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,93% | 803 mld. | |
+40,47% | 629 mld. | |
-7,08% | 351 mld. | |
+17,40% | 324 mld. | |
+10,58% | 303 mld. | |
+15,97% | 244 mld. | |
+1,76% | 226 mld. | |
+10,50% | 215 mld. | |
+6,24% | 164 mld. |